Boston Scientific is a medical device company located in Massachusetts, United States, which is part of the Healthcare sector, and is traded under the ticker BSX on the NYSE exchange.
Boston Scientific stock last closed at $56.50, down 1.93% from the previous day, and has decreased 45.25% in one year. It has overperformed other stocks in the Medical Devices industry by 0.15 percentage points. Boston Scientific stock is currently +0.8% from its 52-week low of $56.05, and -48.4% from its 52-week high of $109.50.
At the moment, there are 1.49B BSX shares outstanding. The market capitalization of BSX is $83.98B. In the past 24 hours, 12.11M BSX shares were traded.
How to Buy Boston Scientific Stock
Not sure how to invest in Boston Scientific stock? Here's how.
Choose where to buy Boston Scientific stock: You need to choose an online brokerage, but don't worry - we've tried dozens of stock brokerages and apps to help you figure out where to buy Boston Scientific stock.
Sign up for a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
Deposit money your brokerage account: Choose your payment method and add your details.
Evaluate Boston Scientific stock: The Boston Scientific ticker symbol is BSX. Is Boston Scientific stock a good investment? Should you buy shares of BSX? How do BSX's underlying business fundamentals look? Do top analysts think Boston Scientific is a good buy? Why has BSX's stock price moved recently? (Hint: Our stock research website can help you figure out if BSX is a good stock to buy).
Execute your BSX trade: Decide if you will purchase BSX shares at the current market price or use a limit order to purchase BSX shares at a given price.
Monitor your BSX investment: Create a watchlist to important notifications about your new investment in Boston Scientific shares.
Step 1: Choose where to buy Boston Scientific stock
You will need an online brokerage account to access the NYSE market and buy BSX shares.
A brokerage account allows you to buy and sell a number of investments, including stocks, bonds, mutual funds, and ETFs.
Our preferred brokerage: eToro
In our opinion, eToro is the best stock brokerage. Here's why:
You can invest in stocks with 0% commissions: Invest without commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
Access to global financial markets: From Technology to Real Estate, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top exchanges.
Social investing: eToro offers a community with more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of top investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by creating an account with eToro today. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Sign up for a brokerage account
Now that you've picked the right brokerage, it's time to fill out some personal info so you are able to buy BSX stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Evaluate Boston Scientific stock
Once you have figured out the best place to buy Boston Scientific stock, it's crucial to research their stock before you buy, so you truly understand the risk and opportunity.
Boston Scientific quick stats
BSX Price
$56.50
1w %
-8.97%
1y %
-45.25%
5y %
29.5%
P/E
23.44x
P/B
3.25x
P/S
4.07x
PEG
1.04x
Revenue
$20.62B
Earnings
$3.57B
Fore. Rev. Growth
9.62%
Fore. Earn. Growth
22.54%
Market Cap
$83.98B
Next Earnings
N/A
Next Dividend
N/A
Boston Scientific Due Diligence Checks
WallStreetZen was designed to help everyday investors do more accurate fundamental analysis.
You can see all of the due diligence checks on BSX's stock page.
Is BSX stock undervalued or overvalued?
You can use many financial metrics, analyses, models, and charts to gauge BSX's true value.
Using relative valuations ratios:
BSX may be overvalued based on its P/E ratio of 23.44x, relative to Medical Devices industry P/E ratio of 20.42x
BSX could be overvalued based on its P/B ratio of 3.25x, relative to Medical Devices industry P/B ratio of 3.03x
BSX could be overvalued based on its PEG ratio of 1.04x
BSX profit margin has gone up from 11.6% to 17.3% in the past year.
BSX earnings of $4.11B is not sufficient to cover its interest payments.
BSX's operating cash flow of $4.34B allows it to safely service it's debt of $11.03B.
There are more short-term assets than short-term liabilities on the BSX balance sheet.
Total BSX debt is lower than 5 years ago, relative to shareholder equity.
Negative Health Checks:
There are more long-term liabilities than short-term assets on the BSX balance sheet.
BSX has a relatively high debt to equity ratio of 0.71.
Is BSX stock a Buy, Hold, or Sell, according to analysts?
Out of 20 Wall Street analysts who monitor BSX, the consensus analyst rating on Boston Scientific is a Strong Buy
Please keep in mind that analyst forecasts are not stock recommendations, nor are they financial advice.
Latest BSX Analyst Ratings
Richard Newitter, a top 17% analyst from Truist Securities maintains BSX with a strong buy rating and lowers their BSX price target from $90.00 to $85.00, on Apr 23, 2026.
David Rescott, a top 21% analyst from Baird maintains BSX with a buy rating and lowers their BSX price target from $86.00 to $78.00, on Apr 23, 2026.
David Roman, a bottom 8% analyst from Goldman Sachs maintains BSX with a strong buy rating and lowers their BSX price target from $87.00 to $84.00, on Apr 23, 2026.
Mike Matson, a top 38% analyst from Needham maintains BSX with a buy rating and lowers their BSX price target from $97.00 to $77.00, on Apr 23, 2026.
Matthew Taylor, a top 18% analyst from Jefferies maintains BSX with a strong buy rating and lowers their BSX price target from $110.00 to $100.00, on Apr 22, 2026.
Last year, BSX earnings were $3.57B. In the past five year, BSX's earnings have grown by 76.68% per year. This was faster than the Medical Devices industry average of 20.69%.
Last year, BSX revenue was $20.62B. During the past 5 year, BSX's revenue has increased by 15.29% per year. This was faster than the Medical Devices industry average of 10.8%.
No, Boston Scientific doesn't provide an income stream by paying out dividends.
What do other traders have to say about BSX?
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other traders have to say.
Step 5: Execute your BSX trade
There are two main options:
Market order: A market order is an order to buy or sell a stock at the best possible price. Market orders are generally sufficient.
Limit order: A limit order is an order to buy or sell a stock at a specific price (or better). If you want to be certain you're buying or selling at a specific dollar amount, place a limit order.
Press the Open Trade button and eToro will execute your order.
If you want additional info about buying stocks on eToro, click the how to video below:
How much does it cost to buy one Boston Scientific share?
As of May 1, 2026, it costs $56.50 to buy one share of Boston Scientific stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.177 shares of BSX.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.